It is noteworthy that HSPG2 is significantly highly expressed in CD34+ cells of AML patients, suggesting that perlecan is indeed secreted by the hematopoietic stem/progenitor cells in AML, even though that perlecan is known to be produced from mesenchymal stem cells37. The gene discussed is CD34; the disease is acute myeloid leukemia.